Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment (NCT05080569) | Clinical Trial Compass
RecruitingPhase 4
Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment
Netherlands1,008 participantsStarted 2023-03-01
Plain-language summary
The LUMO study is a multicenter, randomized controlled trial that evaluates the effectivity of luteal phase support in MOH/IUI treatment.
Who can participate
Age range18 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Couples starting IUI with Mild Ovarian HyperStimulation (MOH), with the intend to receive this treatment for at least six months.
* Diagnosis of unexplained (primary or secondary) infertility
* Hunault \<30% (or \>30%, after an expectant management period of at least 6 additional months).
* Females aged \>18 years with regular menstrual cycle.
* Total mobile sperm count (VCM) \>10 million.
Exclusion cirteria:
* Cycle irregularities
* Male factor infertility